Immunome

Immunome is a biopharmaceutical company using proprietary human memory B cell platform to develop antibody therapeutics.

hooded boxer in boxing ring
Biotech

Immunome's desmoid tumor treatment triumphs in phase 3

The therapy cut the risk of disease progression or death by 84% for patients with desmoid tumors, data one analyst calls a “near best-case outcome.”
Gabrielle Masson Dec 15, 2025 10:42am
pay deal hand over cash licensing transaction money

Immunome pays $50M for Ayala's phase 3 desmoid tumor drug

Feb 6, 2024 9:50am
christmas stocking holiday tree festive

Christmas deal spree: See what J&J, Roche had in their stockings

Jan 2, 2024 7:35am
parachute chutes and ladders

Google DeepMind vet to join GSK—Chutes & Ladders

Oct 20, 2023 9:30am
parasail Blue Lagoon parachute

Abbvie's president adds COO title—Chutes & Ladders

Jun 30, 2023 9:30am
Pac man eat MA deal buy sell merger

Immunome, Morphimmune reverse merge with Clay Siegall as CEO

Jun 29, 2023 10:50am